A brinzolamide (BRN) formulation incorporating two varieties of PLGA nanoparticles was injected in the subconjunctival space of normotensive Albino rabbits. The reduction of IOP in both of those BRN-loaded PLGA nanoparticle preparations was increased than topical BRN suspension on your own for as many as 10d[24]. Other subconjunctival nanoparticle